Pharmaceuticals led by Lilly, Roche and Pfizer have exciting drugs to fire up their growth.
An analyst says the cancer drug company may fetch a 55% premium in a buyout.
The buy will support efforts to tap growth opportunities in the orthopedics market.
The world's largest drugmaker plans to spin off its animal health unit, which should boost its stock.
Ophthotech says its drug, combined with a Roche treatment showed impressive results treating elderly patients with a blinding disease.
Research coming out of the annual event is watched closely by Wall Street.
In an attempt to avoid a hostile takeover by GSK, the company enters talks with several other major companies.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Plus, after much ado, Softbank is oh-so-close to acquiring Sprint.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Those shackled with student loan debt are increasingly being targeted by scams and shady companies promising relief.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.